Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays. - Wikidata - awgldk - TriplyDB

Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays.

Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays.

http://www.wikidata.org/entity/Q33587856

about

Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test

P2860

Q36587825-395D9857-6451-41B4-9707-5EF088447FC9

P2860

Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays.

http://www.wikidata.org/entity/Q33587856

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@ast

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@en

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@nl

type

label

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@ast

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@en

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@nl

prefLabel

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@ast

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@en

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@nl

P1433

Q33587856-FFA042DD-B4F0-4CC5-A47B-08681E89B737

P1476

Q33587856-08AF9EC1-EFDA-46FC-84EB-EF97C41E2BC6

P2093

Q33587856-28F8BD0B-4959-499D-8272-0837983902CA

Q33587856-70965080-B0A3-444C-B8AA-42ADFF2DF77B

Q33587856-7EDA8391-FBA6-4BF6-AC2E-7DA06F965687

Q33587856-800D2C40-FDB1-4D2E-926F-90A3A27ED262

Q33587856-8BE06F6B-EB24-495F-A326-C4C1F2479F41

Q33587856-CD1059EA-BE7A-469F-A803-9861129F45EF

Q33587856-D11E5FB8-9841-4814-9A96-18582A221504

Q33587856-D4B10E42-1B6F-425A-AA23-9DAEFB741B6A

P2860

Q33587856-0D2EF5F8-0852-480B-92AF-EA6A2D36AFB6

Q33587856-1928BB97-3136-4B71-8531-31475356FC79

Q33587856-1B7227D9-7450-42A2-89BC-57309C30B4D5

Q33587856-2BB4ABD3-F9FB-4098-B36E-523A4409E20D

Q33587856-5F19C0BB-A134-4350-B6DB-D5F59E463F4D

Q33587856-7259B384-A0B1-425D-9276-02C71336B1DC

Q33587856-7311CBF3-5D07-43E7-B659-F41CC7EA8478

Q33587856-837B64CB-26F3-44CA-BA67-476F5BF80FDC

Q33587856-A9F98AF0-8C47-4430-ABAA-86900DF9D2DC

Q33587856-B4D9020C-6E59-4F8D-A784-9200E0BF4C6A

P2888

Q33587856-F2C12DF5-0DA0-4EC4-A8F0-25AF75DFBAA3

P304

Q33587856-668440A2-2EB5-45F2-B6E8-F371965F55CB

P31

Q33587856-B368A31D-00F1-4C5C-9C2F-D0BC6679B81D

P356

Q33587856-4E884F41-B1F1-492C-AF42-F390A24BAA3C

P478

Q33587856-0A0D2BFC-051E-43F0-A479-8B42ECCEBE1E

P50

Q33587856-8018CA90-763F-4F69-A8AB-52BA4EFC144A

P577

Q33587856-FC0941C5-105A-42D5-8061-38B451DA0282

P5875

Q33587856-E19ACA19-4773-44C2-87AC-41B3BBF63E40

P6179

Q33587856-E8A3F2E0-4F53-45D7-AE89-C9DEEE102903

P698

Q33587856-B3A67096-2560-46BE-ABFC-BA703D00D1CC

P932

Q33587856-D8E4D722-4763-42E9-B505-AB3CD4609518

P356

1471-2334-13-499

P1433

BMC Infectious Diseases

P1476

Comparison of the performance ...... Qiagen LiquiChip® HPV assays.

@en

P2093

Audrey Raimondo

http://www.w3.org/2001/XMLSchema#string

Claire Camus

http://www.w3.org/2001/XMLSchema#string

Hacène Khiri

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Mateos Lindemann

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Sandri

http://www.w3.org/2001/XMLSchema#string

Mario Sideri

http://www.w3.org/2001/XMLSchema#string

Philippe Halfon

http://www.w3.org/2001/XMLSchema#string

Sophie Ravet

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Papillomaviruses and cancer: from basic studies to clinical application

Epidemiologic classification of human papillomavirus types associated with cervical cancer

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.

Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.

Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica

The natural history of cervical HPV infection: unresolved issues.

HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test.

P2888

1471-2334-13-499

P304

499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-13-499

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Guillaume Penaranda

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258042471

http://www.w3.org/2001/XMLSchema#string

P6179

1006072123

http://www.w3.org/2001/XMLSchema#string

P698

24156822

http://www.w3.org/2001/XMLSchema#string

P932

4015444

http://www.w3.org/2001/XMLSchema#string